Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | 7 | 0 | 0 | 0 | €274.70 | €352.72 | 28.402% |
| Ironwood Pharmaceuticals | 2 | 0 | 0 | 0 | €3.14 | €7.68 | 144.459% |
| Icu Medical Inc. | 8 | 0 | 1 | 0 | €121.00 | €154.35 | 27.562% |
| Alkermes plc | 17 | 0 | 4 | 0 | €25.00 | €38.70 | 54.809% |
| Medpace Holdings Inc | 5 | 5 | 1 | 0 | €470.60 | €416.12 | -11.577% |
| Iovance Biotherapeutics Inc. | 17 | 2 | 0 | 0 | €1.89 | €15.72 | 733.880% |
| Globus Medical A | 1 | 0 | 0 | 0 | €75.50 | €76.00 | 0.662% |
| Neogen Corp. | 4 | 0 | 0 | 0 | €5.15 | €11.85 | 130.037% |
| Ensign Group Inc. | 9 | 0 | 1 | 0 | €153.00 | €159.91 | 4.515% |
| Chemed Corp. | 9 | 0 | 1 | 0 | €360.00 | €515.26 | 43.127% |
| Haemonetics Corp. | 17 | 1 | 2 | 0 | €72.00 | €76.78 | 6.638% |
| Select Medical Holdings | 7 | 0 | 0 | 0 | €12.60 | €21.97 | 74.325% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €111.15 | - | - |
| Alnylam Pharmace. | 51 | 0 | 0 | 0 | €393.40 | €456.30 | 15.988% |
| Amedisys Inc. | 1 | 0 | 0 | 0 | €84.50 | €88.29 | 4.485% |
| Merit Medical Systems | 31 | 0 | 2 | 0 | €71.00 | €95.59 | 34.635% |
| United Therapeutics | 24 | 1 | 0 | 0 | €415.90 | €480.20 | 15.460% |
| GN Store Nord A/S | 1 | 0 | 0 | 0 | €13.96 | - | - |
| Sage Therapeutics Inc. | 1 | 2 | 0 | 0 | €7.60 | €6.69 | -11.991% |
| Icon plc | 21 | 0 | 0 | 0 | €159.60 | €203.65 | 27.599% |
| LivaNova plc | 15 | 0 | 2 | 0 | €54.50 | €57.19 | 4.939% |
| Xencor Inc. | 15 | 2 | 1 | 0 | €15.30 | €22.87 | 49.490% |
| Mednax Inc | 4 | 0 | 1 | 0 | €19.80 | €17.39 | -12.169% |
| Omnicell Inc. | 8 | 0 | 0 | 0 | €34.40 | €35.26 | 2.500% |
| Arrowhead Pharmaceuticals Inc. | 19 | 0 | 6 | 0 | €52.76 | €64.41 | 22.087% |